Support the development of medicine industry innovation in sichuan developed the highest prize in 5 million 

 
Release date: 2015-03-17 14:16:01 | source: sichuan daily | author: Li Longjun 

    Clear: in our province developed a reward, innovation failure can be compensated
 
    By 2020, the formation of 50 state-level innovation platform, 100 provincial level innovation platform, the entire province Chinese herbal medicine planting area of 4 million mu, a Chinese herbal medicine production quality management standard (GAP) base 50, the pharmaceutical industry to achieve high-level talent "millions"
 
    Post invention by persons involved into successful, can be enjoyed by no less than 70% of the proportion distribution of net income
 
    Medical researchers encourage institutions of higher learning, scientific research institutions, participate in industry-university-institute cooperation in part-time and pay way, as a part-time or absences reserve way entrepreneurship, participated in or presided over the enterprise scientific research activities
 
    To get the drugs such as national new drug certificates for the first time in sichuan industrialization, giving the highest reward 5 million yuan; 1, 2 class of investment countries new drug innovation failure, such as research and development of a single project has invested 10 million yuan of above, offer certain risk compensation after that. A few days ago, general office of the provincial government issued "to accelerate the development of medicine industry innovation implementation opinion", for the pharmaceutical industry in our province to support the innovation and development of the whole industry chain. In the industry view, "opinion" failure of compensation in the domestic leading to innovation, support than ever before.
 
    Aimed at full diameter medicine industry scale in 2020, 500 billion yuan on the step of target, the "opinions" put forward seven key work plan, involving the joint innovation, technology upgrade and development of traditional Chinese medicine, industry, market circulation, personnel training, opening up and cooperation, etc.
 
    For research and development institutions and drug firms is more exciting, "opinion" is the innovation and development are the support of policy, real gold and silver and tolerant attitude towards innovation failure.
 
    "Opinion" is put forward, and support for new drug research and development forward extension to the front of the clinical, research and development of preclinical and clinical stage created in stages support; Failure to innovation, r&d has occurred in a certain proportion of compensation. To obtain the national pharmaceutical industry innovation platform and so on, to get the authentic Chinese herbal medicine planting bases, GAP certification pharmaceutical enterprise r&d case such as reach or exceed 3% of operating revenues, offer certain benefits or rewards.
 
    To lead the various types of social capital into the pharmaceutical industry, "opinion" is put forward for financial institutions to the corresponding key pharmaceutical enterprises, such as small pharmaceutical enterprise lending institutions shall be rewarded. Our province will also support to set up the medicine industry innovation, venture capital funds, financial capital to form a complete set of or fund shares. "Opinion" support transformation of scientific research and protect the rights and interests of developers, put forward position by unit after the success of the transformation of scientific and technological achievements, the achievement person that finish to give a one-off reward, at the same time in the patent period extracted from after-tax earnings not less than 5% a year as inventor paid (the designer). For a year without transformation of pharmaceutical service invention achievement, the achievement person that finish or team has achievements disposition.
 
    In market circulation, "opinion" is given in public procurement, price and marketing aspects of provincial new drugs, health services, medical equipment and other aspects of encouraging policies, social do medical and health services utilization, water, gas, heat, and public medical institution to perform the same price policy.
 
    About the rewards and subsidy funds, our province will be incorporated into the special fiscal funds made department support, and budget plan as a whole.